Real World Clinical Outcomes and Patient Characteristics for Canagliflozin Treated Patients in a Specialty Diabetes Clinic.
CONCLUSIONS: CANA was associated with a statistically and clinically significant reduction in A1c, weight, and blood pressure when added to multiple diabetes medication regimens by prescribers in a diabetes clinic.
PMID: 27646315 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Canagliflozin | Diabetes | Diabetes Type 2 | Electronic Health Records (EHR) | Endocrinology | Health | Insulin | Invokana | Nutrition | Research | Sports Medicine | Statistics | Study